Recurrent Inflammatory Breast Carcinoma (DBCOND0084501)
Identifiers
- Synonyms
- Recurrent Breast Inflammatory Carcinoma
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05041101 Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer treatment 1 / 2 terminated NCT03202316 Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer treatment 2 active_not_recruiting NCT02411656 Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy treatment 2 active_not_recruiting NCT02892734 Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer treatment 2 terminated NCT02658812 Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery treatment 2 terminated